Business Context and Reporting Period
Company: Oramed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 15, 2011
Event: Announcement of a scheduled presentation by Dr. Ehud Arbit, Director of R&D, at the 8th Annual Israel Strategic Partner and Venture Conference in Princeton, NJ, on September 22, 2011.
Financial Metrics
This filing is a Current Report (Form 8-K) regarding a corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes or operational updates were reported in this filing. The document solely discloses the upcoming conference presentation.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms Dr. Arbit's participation in the conference to discuss the company's activities.
Guidance/Risks: No forward-looking guidance, risk factors, contingencies, or unusual items are disclosed in this specific report.
Key Facts for Investor Verification
- Dr. Ehud Arbit is scheduled to present on September 22, 2011, at 4:30 p.m. ET.
- The event is the 8th Annual Israel Strategic Partner and Venture Conference held at the Bristol-Myers Squibb Pharmaceutical Research Institute.
- A press release detailing the event is attached as Exhibit 99.1.
- This filing contains no financial data; investors should refer to recent 10-K or 10-Q filings for financial performance.